Forte Capital LLC Amgen Inc Transaction History

Forte Capital LLC

$796 Million
Q1 2024

A detailed history of Forte Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Forte Capital LLC holds 3,782 shares of AMGN stock, worth $1.19 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

3,782

Previous 4,134 8.51%

Holding current value

$1.19 Million

Previous $1.19 Million 9.66%

% of portfolio

0.13%

Previous 0.17%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $94,642 - $114,245	-352 Reduced 8.51%	3,782 $1.08 Million
Q4 2023 Feb 06, 2024	BUY	$255.7 - $288.46 $27,615 - $31,153	108 Added 2.68%	4,134 $1.19 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $3,935 - $4,886	-18 Reduced 0.45%	4,026 $1.08 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $39,639 - $46,873	-185 Reduced 4.37%	4,044 $897,000
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $73,607 - $89,715	-326 Reduced 7.16%	4,229 $1.02 Million

Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $28,399 - $36,085	124 Added 2.8%	4,555 $1.2 Million
Q3 2022 Oct 21, 2022	BUY	$224.46 - $253.15 $46,687 - $52,655	208 Added 4.93%	4,431 $999,000
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $29,761 - $33,119	-129 Reduced 2.96%	4,223 $1.03 Million
Q4 2021 Jan 20, 2022	SELL	$198.88 - $227.6 $823,363 - $942,264	-4,140 Reduced 48.75%	4,352 $979,000
Q3 2021 Oct 27, 2021	SELL	$212.27 - $248.7 $4.74 Million - $5.55 Million	-22,314 Reduced 72.43%	8,492 $1.81 Million
Q2 2021 Jul 28, 2021	SELL	$233.58 - $259.14 $123,563 - $137,085	-529 Reduced 1.69%	30,806 $7.51 Million
Q1 2021 Apr 22, 2021	SELL	$221.91 - $258.6 $41,275 - $48,099	-186 Reduced 0.59%	31,335 $7.8 Million
Q4 2020 Jan 19, 2021	SELL	$216.38 - $257.67 $76,165 - $90,699	-352 Reduced 1.1%	31,521 $7.25 Million
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $62,886 - $69,934	268 Added 0.85%	31,873 $8.1 Million
Q2 2020 Jul 09, 2020	BUY	$197.81 - $242.74 $1.19 Million - $1.47 Million	6,041 Added 23.63%	31,605 $7.45 Million
Q1 2020 Apr 08, 2020	BUY	$182.24 - $241.7 $47,017 - $62,358	258 Added 1.02%	25,564 $5.18 Million
Q4 2019 Jan 10, 2020	BUY	$189.21 - $243.2 $25,354 - $32,588	134 Added 0.53%	25,306 $6.1 Million
Q3 2019 Oct 09, 2019	BUY	$174.11 - $208.62 $352,050 - $421,829	2,022 Added 8.73%	25,172 $4.87 Million
Q2 2019 Jul 16, 2019	BUY	$166.7 - $195.41 $80,849 - $94,773	485 Added 2.14%	23,150 $4.27 Million
Q1 2019 Apr 08, 2019	BUY	$180.87 - $203.88 $47,568 - $53,620	263 Added 1.17%	22,665 $4.31 Million
Q4 2018 Jan 24, 2019	BUY	$178.4 - $208.25 $98,120 - $114,537	550 Added 2.52%	22,402 $4.36 Million
Q3 2018 Oct 16, 2018	BUY	$185.29 - $208.89 $335,560 - $378,299	1,811 Added 9.04%	21,852 $4.53 Million
Q2 2018 Jul 13, 2018	BUY	$166.05 - $186.51 $177,673 - $199,565	1,070 Added 5.64%	20,041 $3.7 Million
Q1 2018 Apr 17, 2018	BUY	$169.43 - $198.0 $225,341 - $263,340	1,330 Added 7.54%	18,971 $3.23 Million
Q4 2017 Jan 22, 2018	BUY	$168.79 - $188.59 $85,238 - $95,237	505 Added 2.95%	17,641 $3.07 Million
Q3 2017 Oct 11, 2017	BUY	$167.29 - $191.0 $2.87 Million - $3.27 Million	17,136	17,136 $3.2 Million

Others Institutions Holding AMGN

# of Institutions

2,934

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forte Capital LLC , based on Form 13F filings with the SEC.

News

Stay updated on Forte Capital LLC with notifications on news.

Account

Forte Capital LLC Amgen Inc Transaction History